More recently MCL-1 and BCL-2 inhibitors were shown to induce apoptosis of Mtb-infected macrophages suggesting that targeting the intrinsic apoptosis pathway is a valid approach for TB host-directed therapy.48 This evidence concerns the gene BCL2 and tuberculosis.